The US Biosimilar Market: Stunted Growth and Possible Reforms-Reference-Cited by-同舟云学术

The US Biosimilar Market: Stunted Growth and Possible Reforms

Published:2018-12-28 Issue:1 Volume:105 Page:92-100
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Sarpatwari Ameet¹,Barenie Rachel¹,Curfman Gregory¹,Darrow Jonathan J.¹,Kesselheim Aaron S.¹

Affiliation:

1. Program On Regulation, Therapeutics, And Law (PORTAL)Department of MedicineDivision of Pharmacoepidemiology and PharmacoeconomicsBrigham and Women's HospitalHarvard Medical School Boston Massachusetts USA

Funder

Laura and John Arnold Foundation

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1285

Reference81 articles.

1. Davies N.The future of biologics. The Pharma Letter . Accessed November 4 2018.

2. Disruption and maturity: the next phase of biologics.QuintilesIMS. Accessed November 4 2018.

3. Remarks from FDA Commissioner Scott Gottlieb M.D. as prepared for delivery at the Brookings Institution on the release of the FDA's Biosimilars Action Plan.US Food and Drug Administration. Accessed November 4 2018.

4. Early developments in the regulation of biologics;Coleman T.S.;Food Drug Law J.,2016

5. Regulation of vaccines: strengthening the science base

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biosimilar Uptake In The US: Patient And Prescriber Factors;Health Affairs;2024-08-01

2. Assessment of Clinical Benefit, Cost and Uptake of Biosimilars Versus Reference Biologics in Immune-Mediated Inflammatory Diseases in China;2024

3. Investigation of Immunogenicity Assessment of Biosimilar Monoclonal Antibodies in the United States;Clinical Pharmacology & Therapeutics;2023-09-11

4. Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design;Pharmaceutics;2023-07-10

5. ASCO Policy Statement on Biosimilar and Interchangeable Products in Oncology;JCO Oncology Practice;2023-07